The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT)-Reference-Cited by-同舟云学术

The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT)

Published:2018-10 Issue:4 Volume:268 Page:591-601
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Fayanju Oluwadamilola M.,Ren Yi,Thomas Samantha M.,Greenup Rachel A.,Plichta Jennifer K.,Rosenberger Laura H.,Tamirisa Nina,Force Jeremy,Boughey Judy C.,Hyslop Terry,Hwang E. Shelley

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference31 articles.

1. Improved axillary staging of breast cancer with sentinel lymphadenectomy;Giuliano;Ann Surg,1995

2. Breast cancer: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual;Giuliano;CA Cancer J Clin,2017

3. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort;Gianni;Lancet,2010

4. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial;Gianni;Lancet Oncol,2016

5. Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2–positive breast cancer: results from the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial;Piccart-Gebhart;J Clin Oncol,2016

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models;The Breast;2024-08

2. Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022;The Breast;2024-08

3. Early prediction of neoadjuvant chemotherapy efficacy for mass breast cancer based on dynamic contrast‐enhanced magnetic resonance imaging radiomics;MedComm – Oncology;2024-07-29

4. Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer;Oncology Letters;2024-07-11

5. Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus;European Journal of Surgical Oncology;2024-07